Management Algorithm for Interrupting Mother to Child Transmission of Hepatitis B Virus.

[1]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[2]  Noele P. Nelson,et al.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B , 2018, The New England journal of medicine.

[3]  Ming Liu,et al.  The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B , 2018, The American Journal of Gastroenterology.

[4]  Noele P. Nelson,et al.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[5]  X. Zhai,et al.  The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study. , 2018, Vaccine.

[6]  Lanjuan Li,et al.  Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update) , 2017, Journal of clinical and translational hepatology.

[7]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[8]  Hui-hui Zheng,et al.  Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. , 2017, Vaccine.

[9]  X. Wang,et al.  [Influencing factors for non/low-response to hepatitis-B vaccine in infants of HBsAg positive mothers]. , 2017, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[10]  Xiaofeng Liang,et al.  Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers. , 2017, Vaccine.

[11]  C. Coffin,et al.  Viral kinetics in women of child bearing potential with chronic hepatitis B virus following treatment with tenofovir alafenamide or tenofovir disoproxil fumarate , 2017 .

[12]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers With High Viral Load , 2016 .

[13]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.

[14]  Paige L. Williams,et al.  The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs , 2016, Front. Immunol..

[15]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[16]  M. Kumar,et al.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update , 2015, Hepatology International.

[17]  Mei-Hwei Chang,et al.  Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother‐to‐infant transmission of hepatitis B virus , 2015, Hepatology.

[18]  Jen-Jung Pan,et al.  Chronic hepatitis B infection in pregnancy. , 2015, World journal of hepatology.

[19]  M. Falagas,et al.  Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. , 2015, The Journal of antimicrobial chemotherapy.

[20]  S. Locarnini,et al.  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. , 2014, Journal of hepatology.

[21]  S. Locarnini,et al.  Anti‐viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post‐partum flare , 2014, Alimentary pharmacology & therapeutics.

[22]  T. Ji.  Effect of neonatal immunoprophylaxis in mother-to-fetus transmission of HBV and analysis on risk factors for transmission , 2014 .

[23]  Hua Zhang,et al.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. , 2014, Hepatology.

[24]  Jinfeng Liu,et al.  [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen]. , 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[25]  H. Hsu,et al.  Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. , 2013, Journal of hepatology.

[26]  Hongying Hou,et al.  Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. , 2013, The Journal of infection.

[27]  Hong Zhang,et al.  Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers , 2012, Journal of viral hepatitis.

[28]  Wei Zhao,et al.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.

[29]  H. Ren,et al.  [Study on the non-and-low response and its determinants to recombinant yeast-derived hepatitis B vaccines among neonates after primary immunization in Shanghai]. , 2011, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[30]  Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data--United States. , 2011, MMWR. Morbidity and mortality weekly report.

[31]  F. Dabis,et al.  Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 , 2010, Antimicrobial Agents and Chemotherapy.

[32]  Who Publication.  Hepatitis B vaccines: WHO position paper--recommendations. , 2010, Vaccine.

[33]  L. Bracciale,et al.  Impact of Hepatitis B Vaccination in Children Born to HBsAg-Positive Mothers: a 20-year Retrospective Study , 2009, Infection.

[34]  C. Tinelli,et al.  Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. , 1998, Vaccine.

[35]  L. Gallagher.  Hepatitis B. , 2016, Journal.

[36]  S. Yokota.  Mother-to-infant transmission of hepatitis B virus , 1990 .

[37]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[38]  Hepatitis A vaccines WHO position paper , 2022 .